Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 206,139,430 papers from all fields of science
Search
Sign In
Create Free Account
KO 202125
Known as:
KO-202125
, KO202125
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Isoindoles
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
The in vitro and in vivo anti‐tumor effect of KO‐202125, a sauristolactam derivative, as a novel epidermal growth factor receptor inhibitor in human breast cancer
M. Oh
,
Jeong-Yeon Lee
,
+7 authors
G. Kong
Cancer science
2011
Corpus ID: 39906467
Epidermal growth factor receptor (EGFR) is one of the most promising targets for cancer therapy. Here, we show the in vitro and…
Expand
2010
2010
KO-202125, a sauristolactam derivate, induces apoptosis to prevent KB human oral squamous carcinoma cells through inhibition of cyclooxygenase-2 expression
Dae-Ho Leem
,
K. Choi
,
+12 authors
Sung-Dae Cho
European journal of cancer prevention : the…
2010
Corpus ID: 205550171
In a previous study, we demonstrated that cyclooxygenase-2 (COX-2) is overexpressed in Korean patients having oral cancer. The…
Expand
2008
2008
KO-202125, a sauristolactam derivate, induce Apoptosis and G2/M Cell cycle arrest in human oral squamous carcinoma cells through inhibition of cyclooxygenase-2 expression
Sung-Dae Cho
,
K. Choi
,
Jun Hee Kim
,
Ji-Youn Jung
,
N. Cho
2008
Corpus ID: 74268954
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
,
Terms of Service
, and
Dataset License
ACCEPT & CONTINUE